September 4, 2018 Bio/Pharma/CRO M&A, Partnerships

Pall Corporation and Celltheon Form Strategic Partnership for Biotherapeutics Development and Manufacturing With Celltheon Smart™ Expression Platform

PORT WASHINGTON, NY – September 4, 2018: Pall Corporation, a global leader in filtration, separation and purification, has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company. This partnership aligns Pall Biotech equipment and consumables with the Celltheon SMART™ Expression Platform to deliver integrated manufacturing solutions for customers developing... Read more

September 3, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher global visited Genetron Health to jointly develop gene sequencing platform applications

BEIJING, Sept. 3, 2018 /PRNewswire/ — On August 29, 2018, Mr. Joydeep Goswami, the President of Clinical NGS and Oncology Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), and Mr. Peter Vuong, the Director of Global Product Management, Clinical NGS division Thermo Fisher visited the Beijing headquarters of Genetron Health, conducted in-depth discussions on strategic... Read more

August 28, 2018 Environ, Ag./Food & Bev Lab Top-10 M&A, Partnerships Mass Spectrometry

Waters and Restek Co-Marketing Agreement Created with Needs of International Food Safety Laboratories in Mind

The Waters Xevo TQ-GC Mass Spectrometer and Restek Gas Chromatography Consumables Are a Winning Combination for Routine GC-MS Pesticide Residue Analyses and Screening MILFORD, Mass.–(BUSINESS WIRE)–Aug. 28, 2018– Waters Corporation (NYSE:WAT) and Restek Corporationhave entered into a co-marketing agreement in an effort to give food safety laboratories access to the GC-MS instrumentation and consumables they need to perform... Read more

August 28, 2018 Life Science Tools M&A, Partnerships

Horizon Discovery announces collaboration with major pharmaceutical company on single cell RNAseq-linked CRISPR screening

Location: Cambridge, UK 28/08/2018 Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation Single cell RNAseq-linked pooled CRISPR screening offers unparalleled depth of screening data and biological insight New platform will further enhance Horizon’s CRISPR screening capabilities Cambridge, UK, 28 August 2018: Horizon Discovery Group... Read more

August 27, 2018 Industrial M&A, Partnerships

Brooks Automation Announces Agreement to Sell Its Semiconductor Cryogenics Business to Atlas Copco

Brooks Automation Announces Agreement to Sell Its Semiconductor Cryogenics Business to Atlas Copco CHELMSFORD, Mass., Aug. 27, 2018 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today announced that it has entered into a definitive agreement to sell its semiconductor cryogenics business to Edwards Vacuum LLC (a member of the Atlas Copco Group) for $675 million... Read more

August 27, 2018 Life Science Tools M&A, Partnerships

10x Genomics Acquires Epinomics

Furthers 10x Leadership across Genomics Applications; Brings Inventors of ATAC-seq Technology to 10x PLEASANTON, CA.—August 28, 2018—10x Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics, a pioneer in the growing epigenetics space. The acquisition will give 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in... Read more

August 24, 2018 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH

— Bruker’s MALDI Biotyper and IR Biotyper microbiology platforms to be complemented by innovative Hain solutions for molecular diagnostics (MDx) of bacterial and viral infections — Acquisition to expand Bruker’s presence in attractive microbiology and virology infectious disease MDx markets, in support of Bruker’s portfolio transformation — Hain to add expertise in tuberculosis and mycobacteria... Read more

August 23, 2018 M&A, Partnerships

Promega Commits $3 Million to Revive & Restore Science Fund Supporting Catalytic Research Bridging Biotech and Conservation

August 23, 2018 07:52 AM Pacific Daylight Time MADISON, Wisc.–(BUSINESS WIRE)–To support the exploration of new solutions for confronting significant environmental challenges, global biotechnology manufacturer Promega Corporation has pledged $3 million over the next three years to the nonprofit Revive & Restore Catalyst Science Fund. This is the first corporate pledge to a recently launched fund designed to identify... Read more

August 22, 2018 Licensing, IP, and Legal M&A, Partnerships

Takara Bio entered into a licensing agreement relating to Oncolytic Virus "Canerpaturev" with Dong-A ST, South Korea

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more